JPMorgan Chase & Co’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $790K | Sell |
196,000
-398,227
| -67% | -$1.6M | ﹤0.01% | 3847 |
|
|
2025
Q1 | $1.62M | Sell |
594,227
-101,309
| -15% | -$277K | ﹤0.01% | 3380 |
|
|
2024
Q4 | $2.96M | Sell |
695,536
-25,543
| -4% | -$109K | ﹤0.01% | 3148 |
|
|
2024
Q3 | $2.12M | Sell |
721,079
-195,163
| -21% | -$574K | ﹤0.01% | 3229 |
|
|
2024
Q2 | $3.19M | Buy |
916,242
+37,567
| +4% | +$131K | ﹤0.01% | 2803 |
|
|
2024
Q1 | $2.5M | Buy |
878,675
+164,990
| +23% | +$470K | ﹤0.01% | 3010 |
|
|
2023
Q4 | $2.52M | Buy |
713,685
+106,203
| +17% | +$375K | ﹤0.01% | 2999 |
|
|
2023
Q3 | $1.57M | Buy |
607,482
+561,964
| +1,235% | +$1.46M | ﹤0.01% | 3147 |
|
|
2023
Q2 | $179K | Buy |
45,518
+1,945
| +4% | +$7.66K | ﹤0.01% | 4336 |
|
|
2023
Q1 | $147K | Buy |
43,573
+10,326
| +31% | +$34.8K | ﹤0.01% | 4488 |
|
|
2022
Q4 | $119K | Sell |
33,247
-16,912
| -34% | -$60.5K | ﹤0.01% | 4429 |
|
|
2022
Q3 | $203K | Sell |
50,159
-26,916
| -35% | -$109K | ﹤0.01% | 4164 |
|
|
2022
Q2 | $344K | Buy |
77,075
+44,683
| +138% | +$199K | ﹤0.01% | 4061 |
|
|
2022
Q1 | $275K | Buy |
+32,392
| New | +$275K | ﹤0.01% | 4279 |
|
|
2021
Q4 | – | Sell |
-31
| Closed | – | – | 5698 |
|
|
2021
Q3 | $0 | Buy |
+31
| New | – | ﹤0.01% | 5517 |
|
|
2020
Q4 | – | Sell |
-298,314
| Closed | -$3.02M | – | 4888 |
|
|
2020
Q3 | $3.02M | Buy |
298,314
+73,349
| +33% | +$742K | ﹤0.01% | 2534 |
|
|
2020
Q2 | $2.24M | Hold |
224,965
| – | – | ﹤0.01% | 2623 |
|
|
2020
Q1 | $2.18M | Buy |
+224,965
| New | +$2.18M | ﹤0.01% | 2546 |
|